Care of The Older Adults-5Ms of Geriatrics: Ria Paul MD

Download as pdf or txt
Download as pdf or txt
You are on page 1of 33

Care of the Older

Adults- 5Ms of
Geriatrics
Ria Paul MD

Confidential – For Discussion Purposes Only


Objectives

 To understand Geriatric Principles in Primary Care

 To increase understanding of 5 Ms of Geriatrics

Confidential – For Discussion Purposes Only


What are the Geriatrics 5Ms?

Mobility Mind Medications Multicomplexity Matters Most

Created by: Sarah C. Phillips, MD; Chelsea Hawley, PharmD;


Laura Triantafylidis, PharmD; Andrea Wershof Schwartz, MD MPH
Modifications by: Ria Paul MD Tinetti et al, JAGS 2017
Module 1: Mobility

Geriatrics 5M’s: Tinetti, Molnar and Huang, JAGS 2017


Fall Prevalence

CDC, 2017; Hafner, 2014

Confidential – For Discussion Purposes Only


Objectives

 Differenti

 Differentiate between intrinsic and extrinsic fall risk factors

 Become familiar with Timed Up and Go (TUG) Test

Confidential – For Discussion Purposes Only


Fall Risk Factor Modification
Intrinsic Fall Risk Factors Extrinsic Fall Risk Factors
Advanced age Footwear or foot problems
Cardiovascular abnormalities Home hazards
Chronic conditions Improper use of assistive device
Cognitive impairment Multifocal eyeglasses
Functional limitations New glasses prescription
Gait and balance problems Substance use
Medications
Orthostatic hypotension
Vision problems
M. E. Tinetti & Kumar, 2010; STEADI, CDC 2017.

Confidential – For Discussion Purposes Only


Toe to Head Approach
Socks,
shoes,
toenail Musculoskeletal

Bowel
Cardiovascular Bladder
Extrinsic
Factors

Medications,
Sensory

Cognition

Confidential – For Discussion Purposes Only


Timed up and go test

Confidential – For Discussion Purposes Only


CDC Home Safety Checklist

STEADI, CDC 2017.

Confidential – For Discussion Purposes Only


Module 2: Medications

Geriatrics 5M’s: Tinetti, Molnar and Huang, JAGS 2017


Objectives
−Identify when a patient is experiencing
polypharmacy

−Utilize evidence-based tools for deprescribing

−Review the Beers Criteria

Confidential – For Discussion Purposes Only


POLYPHARMACY
PROBLEM
• Disability
• Frailty
• Drug-drug interactions
• Impaired cognition
• Slowed gait speed
How many
meds? >
5

Adverse drug events: 5th leading cause of Gnjidic D et al. J Clin Epidemiol 2012
death Doan J et al. Ann Pharmacother 2013
Langeard et al. Frontiers in Pharmacology 2016

Confidential – For Discussion Purposes Only


Deprescribing

Planned or supervised process of


dose reduction or stopping
medication(s) that may be causing
harm or no longer providing
benefit

Scott IA et al. JAMA. 2015; 175(5):827-834.

Confidential – For Discussion Purposes Only


Deprescribing Protocol

1. Reconcile 2. Consider 5. Implement


3. Assess
all risks/benefits 4. Prioritize and monitor
eligibility
medications of use deprescribing

Scott IA et al. JAMA. 2015; 175(5):827-834.

Confidential – For Discussion Purposes Only


Use Medication Assessment
Tools!
• American Geriatrics Society Beers
Criteria
• Medication Appropriateness Index
• Anticholinergic Risk Scale
• STOPP and START
AGS Beers Criteria 2015
Hanlon JT et al. J Clin Epidemiol.1992
Gallagher P Int J Clin Pharmacol Ther 2008
Ruldolph et al. Arch Intern Med 2008
Phung E et al. Journal of Palliative Medicine 2018

Confidential – For Discussion Purposes Only


Module 3: Mind

Geriatrics 5M’s: Tinetti, Molnar and Huang, JAGS 2017


Objectives

 Apply the Mini-Cog as a screening tool for dementia

 Formulate the initial diagnostic evaluation for dementia

Confidential – For Discussion Purposes Only


Some Dementia Warning Signs

 Trouble remembering • Defers to family


• Problems with self-care
 “Poor historian”
• Unexplained weight
 Appointment mix-ups loss
• Vague symptoms
 Can’t follow instructions

 Getting lost Alzheimer’s Association and National Chronic Care Consortium,


2003.

Confidential – For Discussion Purposes Only


Normal Aging vs Dementia

Preclinical

?
Cognitive

Mild
Decline

Cognitive
Impairment

Dementia

Time (years)

Confidential – For Discussion Purposes Only


Primary Care Evaluation of Cognitive Impairment

Screen Evaluate Manage

GSA KAER Toolkit, 2017.

Confidential – For Discussion Purposes Only


Mini-Cog Test

Confidential – For Discussion Purposes Only


Screen Evaluate Manage

Labs and
History
Imaging
Function Mood

Cognition
GSA KAER Toolkit, 2017.

Confidential – For Discussion Purposes Only


Screen Evaluate Manage

 Neuropsychology (if available)


- Can provide comprehensive, objective information about which cognitive functions are
affected and establish a baseline for future re-evaluations
- Most helpful for MOCA 19-27, SLUMS 18-27, MMSE 18-28

 Specialty physicians

− Geriatrics

− Neurology

 Resource referral

GSA KAER Toolkit, 2017.

Confidential – For Discussion Purposes Only


Screen Evaluate Manage

 Medications for dementia


− Acetylcholinesterase Inhibitors (AChI)
− NMDA Antagonists

Early/mild Middle/moderate Late/severe

Start AChI
Start ±
AChI NMDA antagonist

Confidential – For Discussion Purposes Only


Module 4: Multicomplexity and
Matters Most

Geriatrics 5M’s: Tinetti, Molnar and Huang, JAGS 2017


Multicomplexity

Challenges in caring for older adults


 Multiple chronic diseases
 Limitations of current clinical guidelines
 Limited or no data on older adults
 Multifactorial nature of geriatric problems and
syndromes
 Range of patient preferences
JAGS 2012 patient-centered care for older ad

Confidential – For Discussion Purposes Only


Multicomplexity

American Geriatrics Society


Approach to Older Adults
with Multimorbidity

Patient Look at the Estimate What is Communicate


preferences evidence prognosis feasible a plan

American Geriatrics Society, 2012.

Confidential – For Discussion Purposes Only


What Matters Most?

Tinetti et al, JAGS 2017


What Matters Most?

Confidential – For Discussion Purposes Only


What Matters Most?

• Resources for patients


• www.prepareforyourcare.org
• www.theconversationproject.org
• Resources for providers
• www.vitaltalk.org
• https://eprognosis.ucsf.edu/communication/

Confidential – For Discussion Purposes Only


Multicomplexity

http://cancerscreening.eprognosis.org/

Confidential – For Discussion Purposes Only


Questions?

Confidential – For Discussion Purposes Only 33

You might also like